Literature DB >> 33259273

Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses.

Sarah A Morrow1, Devon Conway2, Tom Fuchs3, Curtis Wojcik3, Mahmut Unverdi3, Faizan Yasin3, Jeta Pol3, Sveltlana Eckert3, David H Hojnacki3, Michael Dwyer4, Robert Zivadinov5, Bianca Weinstock-Guttman3, Ralph Hb Benedict3.   

Abstract

BACKGROUND: Cognition is affected by relapses in persons with multiple sclerosis (PwMS), yet the Expanded Disability Status Scale (EDSS) does not readily detect cognitive changes.
OBJECTIVE: The objective of this study is to improve the detection of cognitive decline during relapses, by incorporating the Symbol Digit Modalities Test (SDMT) into the cerebral Functional System Score (CFSS) of the EDSS.
METHODS: This prospective study recruited PwMS from three dedicated MS centers. All subjects had EDSS, SDMT, and Fatigue Severity Scale (FSS) administered. Subjects experiencing a relapse were assigned to the relapse group (RG). Matched controls from the larger cohort were assigned to the stable group (SG). RG and SG subjects underwent the same evaluation at relapse and 3 months later. Our main outcomes were a modified CFSS (m-CFSS) and modified EDSS (m-EDSS), incorporating SDMT and FSS, accounting for cognitive performance and fatigue rating, during relapse.
RESULTS: The full cohort included 592 subjects; 80 qualified for RG and 72 were matched to the SG. The m-CFSS was significantly higher than CFSS at baseline (median = 2 vs. median = 0, p < 0.001) and relapse (median = 2 vs. median = 1, p < 0.001). The m-EDSS was higher than EDSS (median 3.0 vs. 2.5, p = 0.02) at relapse, where 35 RG subjects (43.8%) had higher m-EDSS than EDSS at relapse.
CONCLUSION: This study demonstrates that incorporating the SDMT and FSS improves the accuracy of the EDSS, by accounting for cognitive changes, during relapse activity.

Entities:  

Keywords:  Expanded Disability Status Scale; Multiple sclerosis; Symbol Digit Modalities Test; cognition; relapses

Year:  2020        PMID: 33259273     DOI: 10.1177/1352458520973618

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  2 in total

1.  Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?

Authors:  Dejan Jakimovski; Ralph H B Benedict; Bianca Weinstock-Guttman; Osman Ozel; Tom A Fuchs; Norah Lincoff; Niels Bergsland; Michael G Dwyer; Robert Zivadinov
Journal:  J Neurol       Date:  2021-02-15       Impact factor: 4.849

2.  Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic.

Authors:  Giuseppe Magro; Stefania Barone; Federico Tosto; Antonio De Martino; Domenico Santange Lo; Lucia Manzo; Angelo Pascarella; Pietro Bruno; Marilisa Pasquale; Antonio Gambardella; Paola Valentino
Journal:  J Neurol       Date:  2022-10-13       Impact factor: 6.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.